WWTR1 and hepatocellular carcinoma: In this review, we will introduce molecular signaling pathways beyond RTK that are aberrantly activated in HCC, that is, YAP/TAZ, Hedgehog, and Wnt/β-catenin signaling pathways, and discuss potential therapeutic strategies targeting the signaling pathways in the context of HCC.